Home / Pharma news / 15th Annual eyeforpharma Philadelphia 2017

15th Annual eyeforpharma Philadelphia 2017

Its eyeforpharma Philadelphia’s 15th year; already the largest, most senior and most influential forum for commercial pharma executives, but now in line for a reboot as we aim to position our industry ahead of the curve. Victory requires far more than just SFE, MCM and KAM – it means becoming the health partner of choice.

We, as patients, are becoming consumers. We’re looking for value. We expect quality and real-time delivery. We are more than just empowered – we’re in charge. 55+ Senior-level Speakers, 450+ attendee’s all tackling the hard hitting theme’s effecting commercial pharma. Find out more here.

Speakers include:

  • Kabir Nath, President & CEO, Otsuka North America
  • Andy Schmeltz, Chief Commercial Officer, Pfizer Internal Medicine
  • Sheldon Koenig, SVP and Global Head Cardiovascular Franchise, Sanofi
  • Julie Gerberding, Executive VP & Chief Patient Office, Strategic Communications, Global Public Policy and Population Health, Merck

This is your opportunity to join the discussion with 2 days of expert presentations, interactive panels, keynote presentations and exclusive networking.

Join the most forward thinking speakers from across North America including C-level, VPs and industry leaders from Shire, Otsuka, GSK, Novartis, Pfizer, Google, Sanofi, Takeda and many more. This is the ideal place to ensure your commercial strategy is prepared for 2017 and beyond.

Check Also

Diabetes-Silent Killer

The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion ...

%d bloggers like this: